(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1344834 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PLPP1 mRNA CTD PMID:22079256 1,1-dichloroethene decreases expression ISO RGD:732311 6480464 vinylidene chloride results in decreased expression of PPAP2A mRNA CTD PMID:26682919 1,2-dimethylhydrazine multiple interactions ISO RGD:732311 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PLPP1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO RGD:732311 6480464 1, 2-Dimethylhydrazine results in increased expression of PPAP2A mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression ISO RGD:732311 6480464 Ethinyl Estradiol results in increased expression of PLPP1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of PLPP1 mRNA CTD PMID:16079270 17alpha-ethynylestradiol multiple interactions ISO RGD:732311 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PLPP1 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of PPAP2A mRNA CTD PMID:26496021 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:732311 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PLPP1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PLPP1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732311 6480464 Tetrachlorodibenzodioxin affects the expression of PLPP1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1344834 6480464 Tetrachlorodibenzodioxin affects the expression of PLPP1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PLPP1 mRNA CTD PMID:21215274 , PMID:32109520 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:732311 6480464 tetrabromobisphenol A results in decreased expression of PLPP1 mRNA CTD PMID:25172293 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1344834 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PPAP2A mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of PPAP2A mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane increases expression ISO RGD:732311 6480464 4, 4'-diaminodiphenylmethane results in increased expression of PLPP1 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PLPP1 mRNA CTD PMID:36041667 4-hydroxyphenyl retinamide increases expression ISO RGD:732311 6480464 Fenretinide results in increased expression of PLPP1 mRNA CTD PMID:28973697 5-azacytidine increases expression ISO RGD:1344834 6480464 Azacitidine results in increased expression of PLPP1 mRNA CTD PMID:19194470 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of PPAP2A mRNA CTD PMID:30047161 acrylamide increases expression ISO RGD:1344834 6480464 Acrylamide results in increased expression of PLPP1 mRNA CTD PMID:32763439 alendronic acid affects expression EXP 6480464 Alendronate affects the expression of PLPP1 mRNA CTD PMID:16079270 all-trans-retinoic acid increases expression ISO RGD:1344834 6480464 Tretinoin results in increased expression of PLPP1 mRNA CTD PMID:23724009 amitrole increases expression EXP 6480464 Amitrole results in increased expression of PPAP2A mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PLPP1 mRNA CTD PMID:16483693 aristolochic acid A decreases expression ISO RGD:1344834 6480464 aristolochic acid I results in decreased expression of PLPP1 mRNA CTD PMID:33212167 arsenous acid increases expression ISO RGD:1344834 6480464 Arsenic Trioxide results in increased expression of PLPP1 mRNA CTD PMID:22521957 benzo[a]pyrene multiple interactions ISO RGD:732311 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PPAP2A mRNA, Benzo(a)pyrene promotes the reaction [AHR protein binds to PLPP1 promoter] CTD PMID:19654925 , PMID:27858113 benzo[a]pyrene decreases expression ISO RGD:1344834 6480464 Benzo(a)pyrene metabolite results in decreased expression of PPAP2A mRNA CTD PMID:26314263 benzo[a]pyrene decreases expression ISO RGD:732311 6480464 Benzo(a)pyrene results in decreased expression of PLPP1 mRNA CTD PMID:23735875 benzo[a]pyrene increases expression ISO RGD:732311 6480464 Benzo(a)pyrene results in increased expression of PLPP1 mRNA CTD PMID:21569818 more ... benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1344834 6480464 7 more ... CTD PMID:20018196 benzo[b]fluoranthene increases expression ISO RGD:732311 6480464 benzo(b)fluoranthene results in increased expression of PPAP2A mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions ISO RGD:732311 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PPAP2A mRNA CTD PMID:27858113 bisphenol A decreases expression ISO RGD:1344834 6480464 bisphenol A results in decreased expression of PLPP1 protein, bisphenol A results in decreased expression of PPAP2A mRNA CTD PMID:25047013 , PMID:34186270 bisphenol A decreases methylation ISO RGD:1344834 6480464 bisphenol A results in decreased methylation of PLPP1 gene CTD PMID:31601247 bisphenol A decreases methylation ISO RGD:732311 6480464 bisphenol A results in decreased methylation of PPAP2A promoter CTD PMID:27312807 bisphenol A multiple interactions ISO RGD:1344834 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PLPP1 gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PPAP2A mRNA CTD PMID:28628672 , PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PLPP1 mRNA CTD PMID:30816183 more ... bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PLPP1 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:732311 6480464 bisphenol A results in increased expression of PLPP1 mRNA, bisphenol A results in increased expression of PPAP2A mRNA CTD PMID:26063408 , PMID:32156529 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PLPP1 mRNA, [bisphenol A co-treated with Estradiol] results in increased expression of PPAP2A mRNA CTD PMID:26496021 , PMID:36041667 Bisphenol B increases expression ISO RGD:1344834 6480464 bisphenol B results in increased expression of PLPP1 protein CTD PMID:34186270 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PLPP1 mRNA CTD PMID:36041667 bisphenol F increases expression ISO RGD:1344834 6480464 bisphenol F results in increased expression of PLPP1 protein CTD PMID:34186270 carbon nanotube increases expression ISO RGD:732311 6480464 Nanotubes more ... CTD PMID:25554681 chlorpyrifos increases expression ISO RGD:732311 6480464 Chlorpyrifos results in increased expression of PLPP1 mRNA CTD PMID:37019170 chrysene multiple interactions ISO RGD:732311 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PPAP2A mRNA CTD PMID:27858113 cobalt dichloride decreases expression ISO RGD:1344834 6480464 cobaltous chloride results in decreased expression of PPAP2A mRNA CTD PMID:26314263 cocaine multiple interactions ISO RGD:732311 6480464 [Cocaine co-treated with FOS protein mutant form] results in decreased expression of PLPP1 mRNA CTD PMID:18355967 dexamethasone multiple interactions ISO RGD:1344834 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PPAP2A mRNA CTD PMID:28628672 diarsenic trioxide increases expression ISO RGD:1344834 6480464 Arsenic Trioxide results in increased expression of PLPP1 mRNA CTD PMID:22521957 dibenz[a,h]anthracene increases expression ISO RGD:732311 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate increases expression ISO RGD:732311 6480464 Dibutyl Phthalate results in increased expression of PLPP1 mRNA CTD PMID:17361019 , PMID:21266533 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of PLPP1 mRNA CTD PMID:18636392 dichlorine decreases expression EXP 6480464 Chlorine results in decreased expression of PLPP1 mRNA CTD PMID:18636392 dicrotophos decreases expression ISO RGD:1344834 6480464 dicrotophos results in decreased expression of PPAP2A mRNA CTD PMID:28302478 diuron decreases expression EXP 6480464 Diuron results in decreased expression of PLPP1 mRNA CTD PMID:25152437 diuron increases expression EXP 6480464 Diuron results in increased expression of PLPP1 mRNA CTD PMID:21551480 divanadium pentaoxide affects expression ISO RGD:732311 6480464 vanadium pentoxide affects the expression of PPAP2A mRNA CTD PMID:26210822 dorsomorphin multiple interactions ISO RGD:1344834 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPAP2A mRNA CTD PMID:27188386 entinostat increases expression ISO RGD:1344834 6480464 entinostat results in increased expression of PPAP2A mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1344834 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPAP2A mRNA CTD PMID:27188386 ethanol increases expression ISO RGD:732311 6480464 Ethanol results in increased expression of PLPP1 mRNA CTD PMID:19167417 fipronil increases expression EXP 6480464 fipronil results in increased expression of PLPP1 mRNA CTD PMID:31881178 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of PLPP1 mRNA CTD PMID:18035473 fluoranthene multiple interactions ISO RGD:732311 6480464 [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PPAP2A mRNA CTD PMID:28329830 folic acid multiple interactions ISO RGD:732311 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PLPP1 mRNA CTD PMID:22206623 fulvestrant multiple interactions ISO RGD:1344834 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PLPP1 gene CTD PMID:31601247 furan decreases methylation EXP 6480464 furan results in decreased methylation of PPAP2A gene CTD PMID:27387713 hydrogen peroxide affects expression ISO RGD:1344834 6480464 Hydrogen Peroxide affects the expression of PLPP1 mRNA CTD PMID:20044591 indometacin multiple interactions ISO RGD:1344834 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PPAP2A mRNA CTD PMID:28628672 irinotecan decreases response to substance ISO RGD:1344834 6480464 PLPP1 protein results in decreased susceptibility to Irinotecan CTD PMID:16734730 iron atom increases expression ISO RGD:1344834 6480464 Iron deficiency results in increased expression of PLPP1 mRNA CTD PMID:20368581 iron(0) increases expression ISO RGD:1344834 6480464 Iron deficiency results in increased expression of PLPP1 mRNA CTD PMID:20368581 isoflavones decreases expression ISO RGD:1344834 6480464 Isoflavones results in decreased expression of PLPP1 mRNA CTD PMID:17374662 lead(0) affects expression ISO RGD:1344834 6480464 Lead affects the expression of PPAP2A mRNA CTD PMID:28903495 leflunomide decreases expression ISO RGD:1344834 6480464 leflunomide results in decreased expression of PLPP1 mRNA CTD PMID:28988120 lipopolysaccharide increases expression ISO RGD:732311 6480464 Lipopolysaccharides results in increased expression of PPAP2A mRNA CTD PMID:27339419 lithocholic acid increases expression ISO RGD:732311 6480464 Lithocholic Acid results in increased expression of PLPP1 mRNA CTD PMID:20359477 menadione affects expression ISO RGD:1344834 6480464 Vitamin K 3 affects the expression of PLPP1 mRNA CTD PMID:20044591 methimazole increases expression EXP 6480464 Methimazole results in increased expression of PPAP2A mRNA CTD PMID:30047161 methotrexate affects response to substance ISO RGD:1344834 6480464 PLPP1 protein affects the susceptibility to Methotrexate CTD PMID:16217747 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of PLPP1 gene CTD PMID:35440735 methyl methanesulfonate increases expression ISO RGD:1344834 6480464 Methyl Methanesulfonate results in increased expression of PLPP1 mRNA CTD PMID:23649840 methylmercury(1+) decreases expression ISO RGD:1344834 6480464 methylmercury II results in decreased expression of PPAP2A mRNA CTD PMID:26314263 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of PLPP1 gene CTD PMID:33148267 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of PPAP2A mRNA CTD PMID:25380136 ochratoxin A decreases expression ISO RGD:1344834 6480464 ochratoxin A metabolite results in decreased expression of PPAP2A mRNA, ochratoxin A results in decreased expression of PPAP2A mRNA CTD PMID:26314263 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PPAP2A mRNA CTD PMID:25729387 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of PLPP1 mRNA CTD PMID:18636392 ozone multiple interactions ISO RGD:732311 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PLPP1 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PLPP1 mRNA CTD PMID:34911549 paclitaxel decreases response to substance ISO RGD:1344834 6480464 PLPP1 protein results in decreased susceptibility to Paclitaxel CTD PMID:16734730 paracetamol affects expression ISO RGD:732311 6480464 Acetaminophen affects the expression of PLPP1 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of PLPP1 mRNA CTD PMID:33387578 paraquat increases expression EXP 6480464 Paraquat results in increased expression of PLPP1 mRNA CTD PMID:32680482 paraquat increases expression ISO RGD:732311 6480464 Paraquat results in increased expression of PLPP1 mRNA CTD PMID:36108500 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of PLPP1 mRNA CTD PMID:19162173 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of PLPP1 gene CTD PMID:33148267 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of PPAP2A mRNA CTD PMID:30047161 pirinixic acid increases expression ISO RGD:732311 6480464 pirinixic acid results in increased expression of PLPP1 mRNA CTD PMID:18445702 potassium chromate multiple interactions ISO RGD:1344834 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PLPP1 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1344834 6480464 potassium chromate(VI) results in decreased expression of PLPP1 mRNA CTD PMID:22079256 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:732311 6480464 Pregnenolone Carbonitrile results in increased expression of PPAP2A mRNA CTD PMID:28903501 raloxifene affects expression EXP 6480464 Raloxifene Hydrochloride affects the expression of PLPP1 mRNA CTD PMID:16079270 SB 431542 multiple interactions ISO RGD:1344834 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPAP2A mRNA CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1344834 6480464 Silicon Dioxide analog results in decreased expression of PPAP2A mRNA CTD PMID:25895662 Soman increases expression EXP 6480464 Soman results in increased expression of PLPP1 mRNA CTD PMID:19281266 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of PPAP2A mRNA CTD PMID:30047161 sulforaphane decreases expression ISO RGD:1344834 6480464 sulforaphane results in decreased expression of PLPP1 mRNA CTD PMID:31838189 sunitinib increases expression ISO RGD:1344834 6480464 Sunitinib results in increased expression of PLPP1 mRNA CTD PMID:31533062 tetrachloromethane affects expression ISO RGD:732311 6480464 Carbon Tetrachloride affects the expression of PLPP1 mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO RGD:732311 6480464 Carbon Tetrachloride results in increased expression of PPAP2A mRNA CTD PMID:27339419 tetraphene multiple interactions ISO RGD:732311 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PPAP2A mRNA CTD PMID:27858113 titanium dioxide decreases expression ISO RGD:732311 6480464 titanium dioxide results in decreased expression of PLPP1 mRNA CTD PMID:23557971 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PPAP2A mRNA CTD PMID:25729387 tributylstannane decreases expression ISO RGD:1344834 6480464 tributyltin results in decreased expression of PPAP2A mRNA CTD PMID:26314263 Tributyltin oxide decreases expression ISO RGD:1344834 6480464 bis(tri-n-butyltin)oxide results in decreased expression of PPAP2A mRNA CTD PMID:26314263 Tributyltin oxide increases expression ISO RGD:732311 6480464 bis(tri-n-butyltin)oxide results in increased expression of PLPP1 mRNA CTD PMID:18958704 Triptolide increases expression EXP 6480464 triptolide results in increased expression of PLPP1 protein CTD PMID:32519852 tris(2-butoxyethyl) phosphate affects expression ISO RGD:1344834 6480464 tris(2-butoxyethyl) phosphate affects the expression of PPAP2A mRNA CTD PMID:29024780 undecane increases expression EXP 6480464 undecane results in increased expression of PLPP1 protein CTD PMID:17337753 valproic acid affects expression ISO RGD:1344834 6480464 Valproic Acid affects the expression of PLPP1 mRNA CTD PMID:25979313 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of PLPP1 mRNA CTD PMID:22570695
